{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:33:39Z","timestamp":1707525219894},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,19]]},"DOI":"10.7759\/cureus.45545","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T13:44:42Z","timestamp":1695131082000},"source":"Crossref","is-referenced-by-count":0,"title":["The Impact of the Initial Phase of the COVID-19 Pandemic on Patients With Autoimmune Bullous Diseases"],"prefix":"10.7759","author":[{"given":"Sinem","family":"\u00d6rnek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betul","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00fczeyyen","family":"G\u00f6n\u00fcl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang C","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020, 395:497-506. 10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.047","article-title":"Diagnosis and classification of autoimmune blistering diseases","volume":"13","author":"Baum S","year":"2014","unstructured":"Baum S, Sakka N, Artsi O, Trau H, Barzilai A. Diagnosis and classification of autoimmune blistering diseases. Autoimmun Rev. 2014, 13:482-9. 10.1016\/j.autrev.2014.01.047","journal-title":"Autoimmun Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15032","article-title":"Therapeutic approaches and targets for treatment of autoimmune bullous diseases","volume":"34","author":"Bardazzi F","year":"2021","unstructured":"Bardazzi F, Loi C, Chessa Marco A, et al.. Therapeutic approaches and targets for treatment of autoimmune bullous diseases. Dermatol Ther. 2021, 34:e15032. 10.1111\/dth.15032","journal-title":"Dermatol Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.01.012","article-title":"Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus","volume":"58","author":"Murrell DF","year":"2008","unstructured":"Murrell DF, Dick S, Ahmed AR, et al.. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol. 2008, 58:1043-6. 10.1016\/j.jaad.2008.01.012","journal-title":"J Am Acad Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.06.032","article-title":"Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts","volume":"66","author":"Murrell DF","year":"2012","unstructured":"Murrell DF, Daniel BS, Joly P, et al.. Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts. J Am Acad Dermatol. 2012, 66:479-85. 10.1016\/j.jaad.2011.06.032","journal-title":"J Am Acad Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-016-0343-4","article-title":"Management of pemphigus vulgaris","volume":"33","author":"Cholera M","year":"2016","unstructured":"Cholera M, Chainani-Wu N. Management of pemphigus vulgaris. Adv Ther. 2016, 33:910-58. 10.1007\/s12325-016-0343-4","journal-title":"Adv Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13581","article-title":"The effect of the \"stay-at-home\" policy on requests for dermatology outpatient clinic visits after the COVID-19 outbreak","volume":"33","author":"Kutlu \u00d6","year":"2020","unstructured":"Kutlu \u00d6, G\u00fcne\u015f R, Coerdt K, Metin A, Khachemoune A. The effect of the \"stay-at-home\" policy on requests for dermatology outpatient clinic visits after the COVID-19 outbreak. Dermatol Ther. 2020, 33:e13581. 10.1111\/dth.13581","journal-title":"Dermatol Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31778-7","article-title":"Pemphigus","volume":"394","author":"Schmidt E","year":"2019","unstructured":"Schmidt E, Kasperkiewicz M, Joly P. Pemphigus. Lancet. 2019, 394:882-94. 10.1016\/S0140-6736(19)31778-7","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt E","year":"2013","unstructured":"Schmidt E, Zillikens D. Pemphigoid diseases. Lancet. 2013, 381:320-32. 10.1016\/S0140-6736(12)61140-4","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1198","article-title":"COVID-19: risk factors for severe disease and death","volume":"368","author":"Jordan RE","year":"2020","unstructured":"Jordan RE, Adab P, Cheng KK. COVID-19: risk factors for severe disease and death. BMJ. 2020, 368:m1198. 10.1136\/bmj.m1198","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16525","article-title":"Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic","volume":"34","author":"Kasperkiewicz M","year":"2020","unstructured":"Kasperkiewicz M, Schmidt E, Fairley JA, et al.. Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic. J Eur Acad Dermatol Venereol. 2020, 34:e302-3. 10.1111\/jdv.16525","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13956","article-title":"Treatment concerns for bullous pemphigoid in the COVID-19 pandemic era","volume":"33","author":"Azimi SZ","year":"2020","unstructured":"Azimi SZ, Firooz A, Murrell DF, Daneshpazhooh M. Treatment concerns for bullous pemphigoid in the COVID-19 pandemic era. Dermatol Ther. 2020, 33:e13956. 10.1111\/dth.13956","journal-title":"Dermatol Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.04.005","article-title":"Treatment considerations for patients with pemphigus during the COVID-19 pandemic","volume":"82","author":"Shakshouk H","year":"2020","unstructured":"Shakshouk H, Daneshpazhooh M, Murrell DF, Lehman JS. Treatment considerations for patients with pemphigus during the COVID-19 pandemic. J Am Acad Dermatol. 2020, 82:e235-6. 10.1016\/j.jaad.2020.04.005","journal-title":"J Am Acad Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1771261","article-title":"Management strategies of autoimmune bullous diseases during the outbreak of 2019 novel coronavirus disease (COVID-19)","volume":"33","author":"Chen P","year":"2022","unstructured":"Chen P, Zhang G, Zhan Y. Management strategies of autoimmune bullous diseases during the outbreak of 2019 novel coronavirus disease (COVID-19). J Dermatolog Treat. 2022, 33:569-70. 10.1080\/09546634.2020.1771261","journal-title":"J Dermatolog Treat"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1037\/0278-6133.27.5.513","article-title":"Physician and patient communication training in primary care: effects on participation and satisfaction","volume":"27","author":"Haskard KB","year":"2008","unstructured":"Haskard KB, Williams SL, DiMatteo MR, Rosenthal R, White MK, Goldstein MG. Physician and patient communication training in primary care: effects on participation and satisfaction. Health Psychol. 2008, 27:513-22. 10.1037\/0278-6133.27.5.513","journal-title":"Health Psychol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13677","article-title":"Views and experiences of dermatologists in Turkey about teledermatology during the COVID-19 pandemic","volume":"19","author":"Altunisik N","year":"2020","unstructured":"Altunisik N, Turkmen D, Calikoglu E, Sener S. Views and experiences of dermatologists in Turkey about teledermatology during the COVID-19 pandemic. J Cosmet Dermatol. 2020, 19:2460-3. 10.1111\/jocd.13677","journal-title":"J Cosmet Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/187830-the-impact-of-the-initial-phase-of-the-covid-19-pandemic-on-patients-with-autoimmune-bullous-diseases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:45Z","timestamp":1707509085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/187830-the-impact-of-the-initial-phase-of-the-covid-19-pandemic-on-patients-with-autoimmune-bullous-diseases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.45545","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,19]]}}}